# This Is A Study Of Bioavailability And Food Effect For Fesoterodine.

> **NCT01286454** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 20 (actual)

## Conditions studied

- Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency

## Interventions

- **DRUG:** fesoterodine
- **DRUG:** fesoterodine
- **DRUG:** fesoterodine
- **DRUG:** fesoterodine
- **DRUG:** fesoterodine
- **DRUG:** fesoterodine

## Key facts

- **NCT ID:** NCT01286454
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01286454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01286454, "This Is A Study Of Bioavailability And Food Effect For Fesoterodine.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01286454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
